Literature DB >> 7671889

Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome.

W S Avila1, M Grinberg, R Snitcowsky, R Faccioli, P L Da Luz, G Bellotti, F Pileggi.   

Abstract

Interruption of pregnancy is usually recommended for pregnant women with Eisenmenger's syndrome. We studied 13 pregnancies in 12 women with this syndrome, who decided to carry on with their pregnancy despite recommendation for therapeutic abortion. The mean age was 27 years. Five patients had ventricular septal defect; two, persistent ductus arteriosus; one, a combination of both; two, atrial septal defect; one, atrioventricular septal defect and one patient a combination of ventricular and atrial septal defects. Mean systolic and diastolic arterial pulmonary pressures were 112.7 and 61.7, mmHg, respectively. There were three spontaneous abortions, one premature labour at 23 weeks of gestation and two maternal deaths during the 23 and 27 weeks of gestation. Seven patients who reached the end of the second trimester were hospitalized until delivery and received heparin (20,000 to 40,000 units per day) and oxygen therapy. Caesarean section was performed in all patients as a result of worsening maternal or fetal clinical condition during the third trimester of gestation. all the mothers were discharged from hospital but one of them died on the 30th day post-partum. Five of the eight infants were premature, three were small babies for gestational age and all were discharged from hospital with the exception of one who died 48 h after birth. In conclusion, although pregnancy should be discouraged in women with Eisenmenger's syndrome, it can be successful. In this study, prolonged bed rest, the use of heparin and oxygen therapy presumably positively influenced maternal and infant outcomes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671889     DOI: 10.1093/oxfordjournals.eurheartj.a060936

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

Review 1.  Transition of care from paediatric to adult services in cardiology.

Authors:  L E Hudsmith; S A Thorne
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

2.  Pregnancy and congenital heart disease.

Authors:  C M Oakley
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

3.  Pregnancy in patients with heart disease: experience with 1,000 cases.

Authors:  Walkiria Samuel Avila; Eduardo Giusti Rossi; José Antonio Franchini Ramires; Max Grinberg; Maria Rita Lemos Bortolotto; Marcelo Zugaib; Protasio Lemos da Luz
Journal:  Clin Cardiol       Date:  2003-03       Impact factor: 2.882

4.  A case of successfully managed pregnancy in a patient with complex cyanotic congenital heart disease.

Authors:  J Y Liu; W K Tan; E L Tan; J L Tan; L K Tan
Journal:  Obstet Med       Date:  2016-11-21

Review 5.  Pregnancy in women with congenital heart disease.

Authors:  Heidi M Connolly
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

Review 6.  Congenital heart disease in pregnancy.

Authors:  C E G Head; S A Thorne
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

Review 7.  Sexual and reproductive health in young people with congenital heart disease: a systematic review of the literature.

Authors:  A Hargrove; D J Penny; S M Sawyer
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

8.  Clinical practice: pulmonary hypertension in children.

Authors:  Daniel De Wolf
Journal:  Eur J Pediatr       Date:  2009-01-16       Impact factor: 3.183

9.  Contraception in patients with heart failure.

Authors:  Tara Sedlak; C Noel Bairey Merz; Chrisandra Shufelt; Kimberly D Gregory; Michele A Hamilton
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

Review 10.  Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Authors:  Nazzareno Galie; Alessandra Manes; Massimiliano Palazzini; Luca Negro; Alessandro Marinelli; Simona Gambetti; Elisabetta Mariucci; Andrea Donti; Angelo Branzi; Fernando M Picchio
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.